Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Double-blind, Active Controlled, Parallel Clinical Trial for the Evaluation of the Efficacy and Safety of CnU Cap. 750 mg in Patients With Cholesterol Gallstone

NCT07005752 is registered in ClinicalTrials.gov with Myungmoon Pharma. Co. Ltd. as lead sponsor.

NCT NCT07005752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07005752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Double-blind, Active Controlled, Parallel Clinical Trial for the Evaluation of the Efficacy and Safety of CnU Cap. 750 mg in Patients With Cholesterol Gallstone
Lead sponsor
Myungmoon Pharma. Co. Ltd.
Phase
Phase 4
Overall status
Recruiting
Start date
July 28, 2025
Completion date
June 13, 2028
Enrollment
484 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cholesterol cholelithiasis